72 search results for lung cancer
Supportive Care
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/supportive-careSpecific Populations
Cancer Resources All Lung Cancer Resources All Non-Hodgkin Lymphomas (NHL) Resources, Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic Version: 2024, Small Cell Lung Cancer Version: 2024, Lung Cancer Screening Version: 2023
https://www.nccn.org/patientresources/patient-resources/guidelines-for-patients/specific-populationsNCCN Guidelines for Patients with Permission Email
Myeloid Leukemia Colon Cancer Esophageal Cancer Head and Neck Cancers: Nasopharyngeal Cancer Oral Cancers Oropharyngeal Cancer Hepatobiliary Cancers: Liver Cancer Gallbladder and Bile Duct Cancers Hodgkin Lymphoma Kidney Cancer Lung Cancer: Early and Locally Advanced Metastatic Malignant, e a a n d Vomiting Cancer Screening Lung Cancer Screening Age-Related Adolescents and Yo u n g, Invasive Metastatic Colon Cancer Kidney Cancer Lung Cancer: Early and Locally Advanced
https://www.nccn.org/docs/default-source/patient-resources/nccn-guidelines-for-patients-with-permission-email.pdf?sfvrsn=94769ebd_2Annual Report
/cancercenters. NCCN Member Institutions Mayo Clinic Comprehensive Cancer Center UC Davis Case, for Breast Cancer 1,318,623 Downloads NCCN Guidelines for Non-Small Cell Lung Cancer 932,195, Cell Lung Cancer are currently available in English and Vietnamese. NCCN 2024 Annual Report 18, at meetings including: - World Conference on Lung Cancer - American Association for Cancer Research, The University of Texas MD Anderson Cancer Center Improving The Detection of Other Cancers in Patients
https://www.nccn.org/docs/default-source/about/annual-report.pdf?sfvrsn=8411082_40Transparency Process
/Attendance Adult Cancer Pain Panel Version: 1.2025 ( Adult Cancer Pain ) Date: 2024-09-19 Transparency Panel Disclosures/Attendance Version: 2.2024 ( Adult Cancer Pain ) Date: 2024-03-06 Transparency Panel Disclosures/Attendance Version: 1.2024 ( Adult Cancer Pain, ( Adult Cancer Pain ) Date: 2022-09-12 Transparency Panel Disclosures/Attendance
https://www.nccn.org/guidelines/guidelines-process/transparency-process-and-recommendationsGuidelines for Patients
Version: 2023 Lung Cancer Screening, Non-Small Cell Lung Cancer - Early and Locally Advanced Version: 2024 Non-Small Cell Lung Cancer - Metastatic, Small Cell Lung Cancer Version: 2024, Cancer Version: 2023 Adrenal Tumors
https://www.nccn.org/guidelines/patientsTreatment by Cancer Type
Treatment by Cancer Type, Version: 1.2025 Non-Small Cell Lung Cancer, Small Cell Lung Cancer Version: 4.2025, . NCCN Guidelines Treatment by Cancer Type, Version: 3.2025 Basal Cell Skin Cancer, Version: 2.2025 Biliary Tract Cancers
https://www.nccn.org/guidelines/category_1PAS Policy Report Precision Medicine Final
for the appropriate biomarker tests. Lung and other cancers require significant surgical intervention, and Implications for Quality, Accessible, and Equitable Cancer Care In recent years, targeted medicines have offered dramatic advancements in cancer care outcomes across a wide variety of cancer types. However, as cancer care becomes increasingly personalized, access to biomarker testing and targeted, , the National Comprehensive Cancer Network (NCCN ® ) conducted a patient advocacy scan
https://www.nccn.org/docs/default-source/oncology-policy-program/pas-policy-report-precision-medicine-final.pdf?sfvrsn=468e4a2b_1Webinars for Patients
Small Cell Lung Cancer (2025) Why Should I Consider a Clinical Trial? (2025) Non-Small Cell Lung Cancer (NSCLC) (2025) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (2024) Myeloproliferative Neoplasms (MPN) (2024) Breast Cancer Screening (2024) Advanced and Metastatic Bladder, , patient resources, breast cancer, lung cancer, recorded webinars, recorded patient webinar, myeloma, NCCN provides free webinars for people affected by cancer and caregivers. These live
https://www.nccn.org/patientresources/patient-resources/patient-webinarsAsia
guidelines for the treatment of lung cancer for patients in Vietnam. Moving forward, the groups plan, nccnchina.org.cn Chinese Gynecologic Cancer Society (CGCS): In collaboration with the Chinese Gynecologic Cancer Society (CGCS) and Shanghai Yanxin Cultural Firm, NCCN will work with the leading cancer care experts in China to translate and adapt NCCN Guidelines for Gynecologic Cancers, including cervical Cancer, Ovarian Cancer, Uterine Neoplasms, Gestational Trophoblastic Neoplasia, and Vulvar
https://www.nccn.org/global/global-program/asiaSubmission Request Form
- 2.2025 B-Cell Lymphomas - 2.2025 Biliary Tract Cancers - 1.2025 Bladder Cancer - 1.2025 Bone, System Cancers - 5.2024 Cervical Cancer - 4.2025 Chronic Lymphocytic Leukemia/Small Lymphocytic, and Esophagogastric Junction Cancers - 3.2025 Gastric Cancer - 2.2025 Gastrointestinal Stromal Tumors, Kaposi Sarcoma - 2.2025 Kidney Cancer - 3.2025 Lung Cancer Screening - 1.2025 Management, - 1.2025 Neuroendocrine and Adrenal Tumors - 1.2025 Non-Small Cell Lung Cancer - 3.2025 Occult
https://www.nccn.org/guidelines/submissions-request-to-the-guidelines-panels/submission-request-formAbout the NCCN Guidelines for Patients
-Small Cell Lung Cancer Digital Health Award Spring 2024 Silver Award Winner for the NCCN, than 25 years, the National Comprehensive Cancer Network® (NCCN®) has developed resources to improve the quality of cancer care. These resources include the award-winning NCCN Guidelines for Patients, discuss options with their cancer care team. This library of free resources is made possible through, recognized for their ability to empower people with cancer and caregivers. Recent Awards
https://www.nccn.org/patientresources/patient-resources/about-the-nccn-patient-guidelinesYoung Investigator Awards
Neelima Navuluri, MD, MPH, Duke Cancer Institute Intervention Mapping to Improve Lung Cancer, . Young Investigator Awards The National Comprehensive Cancer, investigators from NCCN Member Institutions represent tomorrow’s leaders for advancing cancer care. The NCCN, Cancer Center | Mass General Cancer Center A Phase II Sudy of Response-Guided Sacituzumab Govitecan (SG) in Combination with Pembrolizumab in Localized Triple Negative Breast Cancer (SG) – NeoSTAR A2
https://www.nccn.org/education-research/nccn-oncology-research-program/young-investigator-awardsYoung Investigator Awards
Therapy for Colorectal and Esophagogastric Cancers Zachary Frosch, MD, MSHP, Fox Chase Cancer, Cancer Institute Intervention Mapping to Improve Lung Cancer Screening Among Black Veterans Ravi, The National Comprehensive Cancer Network® (NCCN®) and the NCCN Foundation® each, tomorrow’s leaders for advancing cancer care. The NCCN Oncology Research Program (ORP) manages, Rachel Abelman, MD, Dana-Farber/Brigham and Women’s Cancer Center | Mass General Cancer Center
https://www.nccn.org/patientresources/patient-resources/nccn-foundation/young-investigator-awards30 Years of NCCN
for the treatment of cancer and perform outcomes research – and so the NCCN was born. With 13 original NCCN Member, with cancer across the country. Now an alliance of 33 leading cancer centers, NCCN develops resources, as a national alliance to develop and institute standards of care for the treatment of cancer and perform, published to assist in the decision-making process of individuals involved in cancer care to improve patient care and outcomes. The first disease types available were: Acute Leukemia and Breast, Colon, Lung
https://www.nccn.org/home/about/nccn-history/30-years-of-nccnEmployer Toolkit
Guidelines; NCCN Guidelines for Patients: Lung Cancer Screening; NCCN Guidelines for Detection, Quality Cancer Care In order to promote and support the highest quality of cancer care for plan members, , including definitions and references Strategies and Tactics for Delivering High Quality Cancer Care, cancer care, and they may be addressed in any order to appropriately serve the needs of each, professional societies and regulatory agencies, such as the NCCN Guidelines for Treatment by Cancer Type
https://www.nccn.org/business-policy/business/employer-resources/employer-toolkitThe Impact of Policy Regulation on Guideline-Concordant Care Globally Summary Article
specific cancers. One significant step to reduce cancer incidence is to eliminate tobacco usage, based on the WHO EML for cancers with the highest incidence in LLMICs. These cancers include lung, of patients with cancer lack access to essential medicines, crucial health infrastructure, and coordinated multidisciplinary cancer care. One path forward is an active effort from policymakers, cancer types and standardization of care through clinical practice guidelines in oncology. Moreover
https://www.nccn.org/docs/default-source/global/the-impact-of-policy-regulation-on-guideline-concordant-care-globally-summary-article.pdf?sfvrsn=b36df21a_3Advocacy December Toolkit_2021
Cholangiocarcinoma Foundation 4 Fight Colorectal Cancer 6 GO2 Foundation for Lung Cancer 7 ICAN, NCCN Digital Booklet of Patient Advocacy Resources National Comprehensive Cancer Network, , A c c e s s i b l e , a n d Equitable Cancer Care The NCCN Digital Resource Booklet includes, to precision medicine and address related needs for people with cancer. This Booklet was developed in conjunction with The National Comprehensive Cancer Network’s ® (NCCN ® ) Virtual Patient
https://www.nccn.org/docs/default-source/oncology-policy-program/advocacy-december-toolkit_2021.pdf?sfvrsn=4c2c60da_1NCCN_Oncology_Research_Program_Brochure
of patients with suspected or newly diagnosed lung cancer in Antelope Valley, one of the most underserved regions of Southern California. Antelope Valley has the highest rate of lung cancer mortality, of the first lung cancer screening program in Antelope Valley. This initiative has touched many, and treatment of lung cancer in this underserved area.” Dan J. Raz, MD City of Hope National Medical Center, that improve the lives of patients with cancer. National Comprehensive Cancer Network® Namrata Vijayvergia
https://www.nccn.org/docs/default-source/oncology-research-program-(orp)/nccn_oncology_research_program_brochure.pdf?sfvrsn=ebab0181_3Detection, Prevention, and Risk Reduction
Lung Cancer Screening Version: 1.2025 Prostate Cancer Early Detection Version: 1.2025, ®) are posted with the latest update date and version number. Breast Cancer, Cancer Screening and Diagnosis Version: 2.2025 Colorectal Cancer Screening Version: 1.2024
https://www.nccn.org/guidelines/category_2